Merz Outsource Compound Management to BioAscent

Posted on:

BioAscent and Merz Pharmaceuticals GmbH, part of the Merz Pharma Group, have entered into a Master Service Agreement (MSA), under which BioAscent provides a comprehensive outsourced compound management service for a significant part of Merz Pharmaceutical’s compound collection, in both … Continued

Read More

Pierre Fabre Collaboration

Posted on:

Pharma and cosmetics multinational Pierre Fabre selects BioAscent as central hub for storage and logistics of extensive plant natural products collection Today, BioAscent announces a new collaboration with pharmaceutical and cosmetics multinational, Pierre Fabre, as part of an open innovation initiative promoting … Continued

Read More

A New Library for Phenotypic Screening: the Annotation Challenge

Posted on:

BioAscent have released a new compound library for phenotypic screening – providing capabilities beyond what is currently available. The Phenotypic Toolbox combines a set of chemically diverse compounds together with reference compounds with known Mechanism of Action. Uniquely, the library is supplied … Continued

Read More

The Revival of a Compound Management Facility

Posted on:

Aaron Sutherland and Steven Russell will explain at Titian Users Group Meeting on 20-21 May in London how recommissioning our facility with Titian’s Mosaic Software was essential to the success of our operations. Read more on the white paper, The Revival of a … Continued

Read More

Novel Cell Penetration-Designed Compound Set

Posted on:

Drug discovery open innovation – beyond the Rule of 5. Do you have a novel cell-based assay? Looking to find novel compounds custom designed to penetrate cells? Our partner is offering access to a compound set designed with specific biological … Continued

Read More
Compound Exchange

Accelerating Drug Discovery Innovation

Posted on:

Compound collections are a valuable corporate asset capable of being utilised to promote and drive innovation in early-stage drug discovery. In our article in the EBR journal, we review current models aiming to maximise the return on investment of compound … Continued

Read More